Drug intelligence / Profile preview

Advanced Immunotherapy for Acute Myeloblastic Leukemia

Development stage: Preclinical
Lead developer: Biohellenika
Modality: Adoptive Cell Transfer → Cell Therapies, Nanoparticles → Drug Delivery Systems

Overview

Advanced Immunotherapy for Acute Myeloblastic Leukemia is a preclinical cell therapy program being developed by Biohellenika Biotechnology Company. The therapeutic approach involves the activation of T-lymphocytes using antigen-presenting cells and cord blood-derived hematopoietic cells to target tumor antigens specifically associated with Acute Myeloblastic Leukemia (AML). The program incorporates a nano-delivery system designed to enhance the targeting and activation of the immune response. This adoptive T-cell approach aims to provide a more effective treatment for AML by leveraging the unique properties of cord blood cells and advanced delivery technologies to stimulate a robust anti-tumor immune response.

Other names: Biohellenika Biotechnology Company-tumor antigens-antigen-presenting cells-cell therapy-T-lymphocyte activation / adoptive T-cell approaches-nano-delivery-cord blood hematopoietic cell therapy-Acute Myeloblastic Leukemia (AML)

Beyond the preview

Go deeper on Advanced Immunotherapy for Acute Myeloblastic Leukemia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Immunotherapy for Acute Myeloblastic Leukemia.

Explore the full profile